Thank you!
Your support is sustaining the future of local news in our communities.

Study focus: treatment of dementia

Of all the diseases that afflict us, dementia is one of the most terrifying because we see it coming and it is inexorable. It takes the mind but leaves the body. We have theories about what causes Alzheimer’s disease — tangles of a protein called beta-amyloid and over-expression of another protein called tau. These proteins in altered forms were thought to be a cause but removing them from most of the cells in the brain using monoclonal antibodies, did not improve symptoms by much. Perhaps the intervention was too late. Both proteins are probably involved but neither has been a fertile source of treatments, and most clinical trials have failed.

I worked in a Department of Pathology and Cell Biology at Columbia University Irving Medical Center where there are basic scientists and pathologists. A pathologist friend lamented the lack of progress for dementia and Parkinsonism as professionally embarrassing. Heart disease, inflammatory diseases, diabetes, cancer, and other conditions have fared better; there are new and effective treatments to extend life and restore independence, most stemming from basic research in cell biology.

There are many cures offered on the internet, but most are wishful thinking or fraud. One study bears watching: it suggested that vaccination for shingles, a painful rash caused by lingering chickenpox virus (Herpes zoster), reduces the number of cases of dementia in older people. Herpes zoster is a neurotropic virus, that selectively infects nerve cells, whose connections, or synapses in the parts of the brain dedicated to memory are the cellular basis of memory. Each nerve cell has 10,000 or more connections with other neurons.

The study in question hangs on a decision made by the UK’s National Health Service after the Shingrix vaccine became available in 2013. NHS decided to give the vaccine to people in Wales born after Sept. 1, 1933, but not to those born one week before. The two groups, in Wales, 80 years old in 2013, were otherwise identical.Each part of the study had thousands of patients.

The chickenpox vaccine reduced the number of people who became demented over the next 7 years by about 20%. The paper is from scientists at Stanford and several Swiss and German universities. It is tough statistical sledding to read but the data are serious. Twenty percent of patients is too few to be confident, but too many to ignore. See below for the reference.

There are many cures offered on the internet, but most are wishful thinking or fraud.

This experiment has been repeated by combining other data from England and Wales. This type of analysis, involving thousands of patient records, has become possible by keeping records in searchable databases. Other versions of the chickenpox vaccine experiment use a more effective vaccine that became available in 2023. Does the newer vaccine protect better than 20%?Does a vaccine applied when people are younger, or given repeatedly, slow the onset of dementia even better?

Think of a slow acting virus that destroys or inhibits neurons or the synapses involved in memory.It could be Herpes zoster lingering from childhood chickenpox or another virus. The vaccine could induce antibodies and T cells that would stop the progression of the slow virus and stave off dementia.A viral cause of dementia would be extraordinary. And actionable.

A second discovery that may be helpful is the effect of weight loss drugs like Wegovy on dementia. These drugs may also help a number of problems including drug addiction and alcohol abuse.

There are several ways to study the effect of these remarkable drugs. One takes advantage of the fact that loss of brain volume is amarker of Alzheimer’s disease. As the disease progresses damage spreads through the brain and it shrinks, which can be observed by magnetic resonance imaging.

One placebo-controlled trial analyzed 204 patients with mild Alzheimer’s disease at 24 clinics in the United Kingdom. Before the study began, all patients had magnetic resonance imaging of their brains to evaluate structure and volume. Half were given a daily injection of 1.8 milligrams of liraglutide/day, a drug used in weight loss and diabetes, while an equal number received a placebo.Those who received liraglutide lost less brain volume (about 50%) than untreated patients. Cognitive testing was done at 0, 24, and 52 weeks and researchers found that patients who received liraglutide hada slower decline in cognitive function — halfthat of untreated patients. They also said they felt better.

Like the Herpes zoster study the results are not conclusive but at this stage we are looking for a new approach, not miracles. Liraglutide and other GLP-1 analogues are licensed for obesity and diabetes, so its path to treatment for Alzheimer’sand other dementias could be relatively swift.

Two independent and larger phase 3 trials are underway, with results due at the end of 2025. If the results are correct, oneprediction would be that people who had been on weight loss drugs should not be entering memory care units. That analysis is difficult, and some of the databases are proprietary, but we will follow these experiments.


To join a study, go to clinicaltrials.gov. Use the search function.


A natural experiment on the effect of herpes zoster vaccination on dementia

https://doi.org/10.1038/s41586-025-08800-x


Dementia symptoms and areas of the brain

https://www.alzheimers.org.uk/about-dementia/stage...


Evaluation of Novel GLP-1 analogue in the treatment of Alzheimer’s disease

Authors: Paul Edison et al.

Volume: Volume20, IssueS6

DOI: https://doi.org/10.1002/alz.089799

Published: 09 January 2025

PDF: https://alz-journals.onlinelibrary.wiley.com/doi/p....…

Liraglutide is a glucagon-like peptide-1 (GLP-1) analogue licensed for the treatment of type 2 diabetes mellitus (T2DM). Preclinical evidence in transgenic models of Alzheimer’s disease suggests that liraglutide exerts neuroprotective effects by reducing amyloid oligomers.


Richard Kessin, PhD is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center.Richard Kessin, PhD is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center.

The views expressed here are not necessarily those of The Millerton News and The News does not support or oppose candidates for public office.

Latest News

After conquering Netflix, a local actor tackles high school

Ivan Howe, 13, performs as Peter Pan at the Sharon Playhouse in Sharon, Connecticut. Howe began his acting career on stage at the Playhouse in “Oliver!” in 2023 and has since performed on stage and even taken a supporting role in the Netflix miniseries “Eric” starring British actor Benedict Cumberbatch.

Photo Provided

MILLBROOK — Ivan Howe’s acting career might be growing faster than he is.

In 2023, the Indian Mountain School student and Millbrook native landed his first title role in Sharon Playhouse’s production of “Oliver!” Three years later, he’s about to start high school having shared the screen with Marvel superheroes.

Keep ReadingShow less
Village officials expect new Water Department building by summer’s end

Caroline Farr-Killmer has been leading the effort to rebuild Millerton’s fire-ravaged Water Department building since last February.

Photo by Aly Morrissey

MILLERTON — Village officials expect a rebuild of the fire-ravaged Water Department building to begin soon, with the aim of completing it before the end of summer.

Fire project manager Caroline Farr-Killmer has been managing the effort to demolish and rebuild the village’s Public Works Department building since a fire destroyed it and all the equipment inside last winter. She said that Dutchess County Department of Health approval is the last hurdle for a new Water Department building before construction can start.

Keep ReadingShow less
Thai tea shop venture delayed over septic approvals

Kanchisar Jiradhanaiphat, left, and John Schildbach plan to open Muanjai Tea on Main Street in Millerton in early July.

Photo by Nathan Miller

MILLERTON — The opening of a proposed Thai tea shop on Main Street has been delayed while owners await approval from the Dutchess County Department of Health.

John Schildbach, who plans to open the shop with his wife, Kanchisar Jiradhanaiphat, in the former Candy-O’s space, said plans to include seating have complicated the approval process because of the building’s existing septic system.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

New owners pledge to keep original mission of Babette’s Kitchen

Jennifer Burgen, right, and Michael Burgen now own Babette’s Kitchen on Franklin Avenue in Millbrook. The duo have worked at the shop since 2024.

Photo Provided

MILLBROOK — A local eatery that has operated on Millbrook’s Franklin Avenue for more than 20 years is changing ownership.

The new owners at Babette’s Kitchen are two longtime employees. Jennifer Burgen, who has worked at Babette’s for the last three years, and Michael Burgen, who joined the kitchen in December 2024, took over earlier this month. Michael had previously been a general manager at Fern in Lakeville.

Keep ReadingShow less

Anita L. Gochey

Anita L. Gochey

CANAAN — Anita L. (King) Gochey, 85, of 77 South Canaan Rd. died June 5, 2026, at Geer Village. She was the wife of the late Lester Gochey. Anita was born July 16, 1940,in Winsted, daughter of the late Ivan and Irene (Dulude) King.

Anita was well known throughout the Northwest Corner. She worked for many local businesses and organizations. Anita worked at the Rexall Drug Store, C.A. Lindell and Sons, Bob’s Clothing, Brooks Pharmacy, and the Housatonic Valley Regional High School in the cafeteria.She used her skills in calligraphy to complete the record books for the North Canaan Congregational Church.Anita’s daughter remembers her as being very creative with cardboard, and a loving mom.

Keep ReadingShow less
NECC pilot program places a renewed emphasis on community-building

Carol Kneeland, left, Cyndhia Valle, center, and Irene Banning knit together on North East Community Center’s back porch during the first “Community Porch Party” on Wednesday, June 3.

Photo By Nathan Miller

MILLERTON — A new pilot program at the North East Community Center aims to bring in community members for chill hangs at the nonprofit’s office on South Center Street this summer.

The weekly “Community Porch Party” is an evolution of senior administrative assistant Ash Baldwin’s “Craft Collective,” which invited community members to enjoy a group crafting session where participants were encouraged to bring individual projects, swap tips and be together. The gathering on Wednesday, June 3, and the preceding “Craft Collective” meetings are part of a broader effort to provide accessible, community-building programming.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.